Table 1.
Method/design | Vector yield | Reference | |
---|---|---|---|
AdV-based system | |||
Ad-free, triple plasmid transfection | 120ETU/cell | Matsushita et al. (1998) | |
Transient transfection, pXX2, unconventional start codon to modulate Rep expression | 1.2 × 103ETU/cell 9.4 × 105 vg/cell | Xiao et al. (1998) | |
Rep/Cap Hela stable cell line + AdV | up to 36 IP/cell | Clark et al. (1995) | |
Transient transfection, pSH3/pSH5 plasmids which combined AAV Rep, Cap, and AdV-helper genes | 1.3 × 104 vg/cell 135 ETU/cell |
Collaco et al. (1999) | |
Transient transfection with pDG plasmid, MMLV regulate Rep expression | 150 IP/cell | Grimm et al. (1998) | |
Transient transfection, Mtrep-CMVcap plasmid, E4orf6-only plasmid | 104 vg/cell 23 TU/cell |
Allen et al. (2000) | |
Rep/Cap stable cell line A549 + AdV | 262 TU/cell | Gao et al. (2002) | |
Rep/Cap stable cell line + AdV-Cre vector | 1.3 × 105 vg/cell 1.7 × 103 ETU/cella |
Qiao et al. (2002) | |
Self-replicating Rep/Cap helper construct | 2 × 109 IU/well | Li and Samulski (2005) | |
Transient transfection, Rep/Cap split system | 2.6 × 105 vg/cell 37.8 TU/cell |
Emmerling et al. (2016) | |
HSV-based system | |||
Transient transfection, HSV-rc/d27 amplicon system | 480 vg/cell | Conway et al. (1997) | |
Infection with rHSV-rc strain on AAV-GFP-integrated cell line | 480 ETU/cell | Conway et al. (1999) | |
Infection with rHSV Rep/Cap and rHSV-GFP | 1.5 × 105 vg/cell 6 × 103IP/cell |
Hwang et al. (2003) | |
Double infection with ICP27-deleted rHSV strains | 40 TU/cell | Booth et al. (2004) | |
Production of rAAV serotypes 1,2, and 9, by double infection with ICP27-deleted rHSV strains | > 1.3 × 105 vg/cell > 9 × 103 IP/cell |
Kang et al. (2009) | |
Production of rAAV serotypes 1,2,5 and 8, by using suspension-adapted BHK cells infected with rHSV strains | up to 1 × 105 vg/cell up to 1 × 104 IP/cell |
Thomas et al. (2009) | |
Suspension-adapted BHK cells infected with rHSV strains | > 5 × 104 vg/cell | Knop et al. (2011) | |
BV-based system | |||
Initial design, triple-BV system, Rep/Cap genes controlled by IE1/polh promoters | 5 × 104 vg/cell 30 TU/cell |
Urabe et al. (2002) | |
Swapping of AAV genetic elements from different serotypes to improve production of rAAV5 | 6 × 104 vg/cell | Urabe et al. (2006) | |
Intron-splicing mediated expression | 1 × 1011 vg/mL | Chen (2008) | |
Stable cell line, integration of Rep/Cap sequences + hr2-0.9 homologous regions + RBE sites | > 105 vg/cell | Aslanidi et al. (2009) | |
Stable cell line producing rAAV serotypes 1–12 | up to 5 × 105 vg/cell | Mietzsch et al. (2014) | |
Yeast expression system | |||
4-plasmid system, individual expression cassettes regulated by Gal1/Gal10 promoters | ~ 108 vg/mL | Barajas et al. (2017) |
vg vector genomes, ETU enhanced transducing unit, TU transducing unit, IP infectious particle, IU infectious unit
aAssuming 5 × 106 cells per 10 cm plate were used for assay